Angelini pharma
  • Group
  • Angelini Pharma
  • Who we are

    • Who We Are
    • Vision, mission & values
    • Key facts and events
    • People
  • Core areas

    • Rare Diseases
    • Mental Health
    • Consumer Health
  • From pipeline to health aids

    • Pipeline
    • Products
    • Sites
  • Our Partnerships

    • Partnering
    • Research & Academic Centers and Scientific Institutions
  • Our Responsibility

    • Ethics
    • Quality policy
    • Transparency
    • Sustainability
  • Media

    • News
    • Press releases
    • Archivio Magazine
    • Media center
  • Career Opportunities
  • Open main menu
  • Open main menu
  • Search

    Search

  1. Angelini Pharma
  2. Core areas
  3. The Lancet

The Lancet

The Lancet
  • All articles
  • Mental Health
  • Pain
  • Rare Diseases
  • Consumer Health

Mental Health

  1. Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study

    Large-scale studies with a broad age range are needed to properly address this issue.

    Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study
  2. Efficacy and cost-effectiveness of therapist-guided internet cognitive behavioural therapy for paediatric anxiety disorders: a single-centre, single-blind, randomised controlled trial.

    Efficacy and cost-effectiveness of therapist-guided internet cognitive behavioural therapy for paediatric anxiety disorders: a single-centre, single-blind, randomised controlled trial.
load more

See also

  1. Rare Diseases

    Rare Diseases
  2. Mental Health

    Mental Health
  3. Consumer Health

    Consumer Health
Angelini pharma
  • Terms of use
  • Privacy
  • Transparency
  • Cookie Policy
  • Contact
  • Site map
  • Credits
  • Twitter
  • Linkedin
  • Facebook
  • Instagram
  • YouTube
  • Top Employee

Angelini S.p.a. - Viale Amelia 70, 00181 Roma - P.IVA 01258691003 e C.F. Numero di iscrizione registro imprese: 03907010585 - Ufficio del registro delle imprese: Roma - Capitale: € 165.000.000 I.V.
Copyright 2021 © Angelini S.p.a. - All Rights Reserved

Close menu